The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
The generated wealth of immune repertoire sequencing data requires software to investigate and quantify inter- and intra-antibody repertoire evolution to uncover how B cells evolve during immune responses. Here, we present 'AntibodyForests', a software to investigate and quantify inter- and intra-antibody repertoire evolution.
Version: | 1.0.0 |
Depends: | R (≥ 4.0.0) |
Imports: | ape, Biostrings, dplyr, graphics, grDevices, gtools, igraph, magrittr, parallel, pwalign, rlang, scales, seqinr, stats, stringdist, stringr, tidyr, utils, viridis |
Suggests: | alakazam, base64enc, bio3d, combinat, devtools, DT, fpc, ggplot2, ggrepel, ggsignif, htmltools, knitr, msa, phangorn, pheatmap, Peptides, Rcompadre, rmarkdown, RPANDA, swipeR |
Published: | 2025-01-23 |
DOI: | 10.32614/CRAN.package.AntibodyForests |
Author: | Daphne van Ginneken [aut, cre], Alexander Yermanos [aut], Valentijn Tromp [aut], Tudor-Stefan Cotet [ctb] |
Maintainer: | Daphne van Ginneken <daphne.v.ginneken at gmail.com> |
License: | GPL-2 |
NeedsCompilation: | no |
Materials: | README |
CRAN checks: | AntibodyForests results |
Reference manual: | AntibodyForests.pdf |
Vignettes: |
AntibodyForests vignette: building and analyzing B-cell lineage trees from 10x sc-V(D)J seq data (source, R code) |
Package source: | AntibodyForests_1.0.0.tar.gz |
Windows binaries: | r-devel: AntibodyForests_1.0.0.zip, r-release: AntibodyForests_1.0.0.zip, r-oldrel: not available |
macOS binaries: | r-release (arm64): AntibodyForests_1.0.0.tgz, r-oldrel (arm64): not available, r-release (x86_64): not available, r-oldrel (x86_64): not available |
Please use the canonical form https://CRAN.R-project.org/package=AntibodyForests to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.